Back to Search
ANTONY LOEBEL, M.D.
M.D.
Psychiatry Physician
NPI: 1770821431Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.
PMID 17915970·J Clin Psychiatry·2007
2-rct
Improvement in prosocial functioning after a switch to ziprasidone treatment.
PMID 15115948·CNS Spectr·2004
8-other
Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.
PMID 19616304·J Affect Disord·2010
8-other
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.
PMID 19074536·J Psychopharmacol·2010
4-observational
Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.
PMID 19573482·J Clin Psychiatry·2009
2-rct
Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
PMID 19497249·J Clin Psychiatry·2009
4-observational
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
PMID 19419595·Int J Neuropsychopharmacol·2009
4-observational
Weight effects associated with antipsychotics: a comprehensive database analysis.
PMID 19321312·Schizophr Res·2009
8-other
A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study.
PMID 19175979·Can J Psychiatry·2009
4-observational
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
PMID 19594505·Bipolar Disord·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 18 BEACH AVE
LARCHMONT, NY 10538 - Phone
- (201) 916-6672
Quick Facts
- NPI
- 1770821431
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile